Zars Parma IPO postponed for next week-underwriter

NEW YORK, Sept 20 (Reuters) - Zars Pharma Inc, a Salt Lake City pharmaceutical company, has postponed its initial public offering to next week, an underwriter said on Thursday.

The 5-million share offering was initially expected to price on Wednesday, and then on Thursday.

The company, in an earlier filing with the U.S. Securities and Exchange Commission, said it expected the share offering to sell for between $14 and $16 per share.

Underwriters, led by Cowen & Co and CIBC World Markets, have an option to purchase an additional 750,000 shares to cover overallotments.

The company has been approved to list its stock on Nasdaq under the symbol "ZARS" ZARS.O.

(Reporting by Lilla Zuill)

((Tel +1 646 223 6281; E-mail: Lilla.Zuill@reuters.com)) Keywords: ZARSPHARMA IPO/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN17314116